Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Sep. 24, 1998

Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals

Sep. 24, 1998

Expanded approval requested for chemoprotective agent

Sep. 24, 1998

First chemically synthesized ribozyme heading for human studies for cancer

Sep. 23, 1998

New MMP inhibitors in early development at Ono

Sep. 23, 1998

Kyowa Hakko studies DC-107 derivatives as antitumor/antibacterial agents

Sep. 23, 1998

Cephalon presents CEP-701 at German cancer meeting

Sep. 22, 1998

Takeda describes preparation and use of inhibitors of steroid C17-20 lyase

Sep. 22, 1998

Procyon receives U.S. patent for the use of ANAs in the treatment of cancer

Sep. 22, 1998

Sugen initiates two new trials with lead compound

Sep. 22, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...